The newest innovation in high functionality excipients, PROSOLV® 730, was developed to provide solutions to challenges presented by oily active ingredients and poorly water-soluble, lipophilic substances.
PROSOLV® 730 is a co-processed composite consisting of microcrystalline cellulose, silicon dioxide, and copovidone. Each component is regarded as safe for nutraceutical applications and complies with the corresponding monographs of the Ph. Eur and USP/NF.
PROSOLV® 730 is now available in specific markets, including North America and parts of Europe, and will be globally available in 2023.